• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

传染病和大流行病病毒感染:对结核病和肺部的影响:世界传染病和免疫障碍协会(WAidid)、全球结核病网络(GTN)以及欧洲临床微生物学和传染病学会分枝杆菌感染研究组(ESGMYC)成员的共识。

Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).

机构信息

Dept of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore.

出版信息

Eur Respir J. 2020 Oct 1;56(4). doi: 10.1183/13993003.01727-2020. Print 2020 Oct.

DOI:10.1183/13993003.01727-2020
PMID:32586885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7527651/
Abstract

Major epidemics, including some that qualify as pandemics, such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), HIV, influenza A (H1N1)pdm/09 and most recently COVID-19, affect the lung. Tuberculosis (TB) remains the top infectious disease killer, but apart from syndemic TB/HIV little is known regarding the interaction of viral epidemics and pandemics with TB. The aim of this consensus-based document is to describe the effects of viral infections resulting in epidemics and pandemics that affect the lung (MERS, SARS, HIV, influenza A (H1N1)pdm/09 and COVID-19) and their interactions with TB. A search of the scientific literature was performed. A writing committee of international experts including the European Centre for Disease Prevention and Control Public Health Emergency (ECDC PHE) team, the World Association for Infectious Diseases and Immunological Disorders (WAidid), the Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycobacterial Infections (ESGMYC) was established. Consensus was achieved after multiple rounds of revisions between the writing committee and a larger expert group. A Delphi process involving the core group of authors (excluding the ECDC PHE team) identified the areas requiring review/consensus, followed by a second round to refine the definitive consensus elements. The epidemiology and immunology of these viral infections and their interactions with TB are discussed with implications for diagnosis, treatment and prevention of airborne infections (infection control, viral containment and workplace safety). This consensus document represents a rapid and comprehensive summary on what is known on the topic.

摘要

重大传染病,包括一些符合大流行标准的传染病,如严重急性呼吸综合征(SARS)、中东呼吸综合征(MERS)、艾滋病毒、甲型流感(H1N1)pdm/09,以及最近的 COVID-19,都会影响肺部。结核病(TB)仍然是头号传染病致死原因,但除了结核/艾滋病毒综合征外,人们对病毒流行和大流行与结核病之间的相互作用知之甚少。这份基于共识的文件旨在描述导致肺部出现流行和大流行的病毒感染的影响(MERS、SARS、艾滋病毒、甲型流感(H1N1)pdm/09 和 COVID-19),以及它们与结核病的相互作用。对科学文献进行了搜索。成立了一个由国际专家组成的写作委员会,包括欧洲疾病预防控制中心公共卫生紧急情况(ECDC PHE)小组、世界传染病与免疫障碍协会(WAidid)、全球结核病网络(GTN),以及欧洲临床微生物学和传染病学会(ESCMID)分枝杆菌感染研究组(ESGMYC)的成员。写作委员会和一个更大的专家组经过多轮修订达成了共识。一个德尔菲法(Delphi)流程,涉及核心作者组(不包括 ECDC PHE 小组),确定了需要审查/达成共识的领域,随后进行了第二轮工作,以完善最终共识要素。讨论了这些病毒感染的流行病学和免疫学特性及其与结核病的相互作用,涉及诊断、治疗和预防空气传播感染(感染控制、病毒遏制和工作场所安全)的内容。这份共识文件代表了对该主题的快速而全面的综合总结。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e6/7527651/3aa266423d68/ERJ-01727-2020.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e6/7527651/8da70f246c04/ERJ-01727-2020.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e6/7527651/3aa266423d68/ERJ-01727-2020.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e6/7527651/8da70f246c04/ERJ-01727-2020.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25e6/7527651/3aa266423d68/ERJ-01727-2020.02.jpg

相似文献

1
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).传染病和大流行病病毒感染:对结核病和肺部的影响:世界传染病和免疫障碍协会(WAidid)、全球结核病网络(GTN)以及欧洲临床微生物学和传染病学会分枝杆菌感染研究组(ESGMYC)成员的共识。
Eur Respir J. 2020 Oct 1;56(4). doi: 10.1183/13993003.01727-2020. Print 2020 Oct.
2
Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.结核病和 COVID-19:从过去的病毒爆发中吸取教训和可能的未来结果。
Can Respir J. 2020 Sep 5;2020:1401053. doi: 10.1155/2020/1401053. eCollection 2020.
3
Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide.七种大流行病毒完整蛋白质组与 438 种 HLA 蛋白的结合亲和力,以及全世界人群中最强和最弱 HLA 肽结合物的分布。
HLA. 2020 Sep;96(3):277-298. doi: 10.1111/tan.13956. Epub 2020 Jun 11.
4
Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.SARS-CoV-2、SARS-CoV、MERS-CoV 和甲型流感病毒的比较综述。
Front Immunol. 2020 Sep 11;11:552909. doi: 10.3389/fimmu.2020.552909. eCollection 2020.
5
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?COVID-19、细胞因子和免疫抑制:我们能从严重急性呼吸综合征中学到什么?
Clin Exp Rheumatol. 2020 Mar-Apr;38(2):337-342. doi: 10.55563/clinexprheumatol/xcdary. Epub 2020 Mar 22.
6
Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.关于 SARS-CoV-2 感染潜在发病机制的假说——病毒性肺炎患者免疫变化的综述。
Emerg Microbes Infect. 2020 Dec;9(1):727-732. doi: 10.1080/22221751.2020.1746199.
7
A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option.洛匹那韦疗法治疗严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒的系统评价——为新型冠状病毒病治疗方案提供参考。
J Med Virol. 2020 Jun;92(6):556-563. doi: 10.1002/jmv.25729. Epub 2020 Mar 12.
8
Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season.流行季节冠状病毒和甲型流感病毒引起的呼吸道疾病的比较综述。
Microbes Infect. 2020 Jul-Aug;22(6-7):236-244. doi: 10.1016/j.micinf.2020.05.005. Epub 2020 May 13.
9
A comparative overview of COVID-19, MERS and SARS: Review article.新型冠状病毒病、中东呼吸综合征和严重急性呼吸综合征的比较概述:综述文章。
Int J Surg. 2020 Sep;81:1-8. doi: 10.1016/j.ijsu.2020.07.032. Epub 2020 Jul 26.
10
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征的生物学、临床和流行病学特征,以及 ACE2 的 AutoDock 模拟
Infect Dis Poverty. 2020 Jul 20;9(1):99. doi: 10.1186/s40249-020-00691-6.

引用本文的文献

1
Tuberculosis treatment failure: what are the risk factors? A comprehensive literature review.肺结核治疗失败:危险因素有哪些?一项综合性文献综述。
Multidiscip Respir Med. 2025 Jul 4;20(1):1030. doi: 10.5826/mrm.2025.1030.
2
Inhaled Dry Powder of Antiviral Agents: A Promising Approach to Treating Respiratory Viral Pathogens.抗病毒药物吸入干粉剂:一种治疗呼吸道病毒病原体的有前景的方法。
Viruses. 2025 Feb 12;17(2):252. doi: 10.3390/v17020252.
3
Impact of Severity of COVID-19 in TB Disease Patients: Experience from an Italian Infectious Disease Referral Hospital.

本文引用的文献

1
Mask wearing to complement social distancing and save lives during COVID-19.在新冠疫情期间佩戴口罩以辅助保持社交距离并拯救生命。
Int J Tuberc Lung Dis. 2020 Jun 1;24(6):556-558. doi: 10.5588/ijtld.20.0244.
2
Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.非裔美国人 COVID-19 患者的肺部和心脏病理学:来自新奥尔良的尸检系列。
Lancet Respir Med. 2020 Jul;8(7):681-686. doi: 10.1016/S2213-2600(20)30243-5. Epub 2020 May 27.
3
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
2019冠状病毒病(COVID-19)严重程度对结核病患者的影响:来自一家意大利传染病转诊医院的经验
Infect Dis Rep. 2025 Feb 5;17(1):11. doi: 10.3390/idr17010011.
4
Infectious Risk in Pediatric Emergency Departments in Italy: A Survey by the Italian Society for Pediatric Emergency and Urgent Medicine (SIMEUP) on Available Preventive and Diagnostic Tools.意大利儿科急诊科的感染风险:意大利儿科急诊与急救医学学会(SIMEUP)对现有预防和诊断工具的调查
J Clin Med. 2024 Dec 19;13(24):7762. doi: 10.3390/jcm13247762.
5
Is Respiratory Viral Infection an Inciting Event in the Development of Melioidosis? A Systematic Evaluation of Co-infection With and SARS-CoV-2 or Influenza.呼吸道病毒感染是类鼻疽病发展的诱发事件吗?对与新型冠状病毒或流感病毒合并感染的系统评价。
Open Forum Infect Dis. 2024 Dec 4;11(12):ofae700. doi: 10.1093/ofid/ofae700. eCollection 2024 Dec.
6
Effective Reproduction Number of Smear-Positive Pulmonary Tuberculosis in Iran: A Registry-Based Study (2011-2021).伊朗涂片阳性肺结核的有效繁殖数:基于登记的研究(2011-2021 年)。
J Res Health Sci. 2024 Sep 30;24(4):e00633. doi: 10.34172/jrhs.2024.168. Epub 2024 Jul 30.
7
Changes in incidence and clinical features of tuberculosis with regard to the COVID-19 outbreak in Southern Iran.伊朗南部 COVID-19 疫情暴发前后结核病发病率和临床特征的变化。
BMC Infect Dis. 2024 Sep 27;24(1):1043. doi: 10.1186/s12879-024-09947-0.
8
The impact of pulmonary tuberculosis on SARS-CoV-2 infection: a nationwide cohort study.肺结核对严重急性呼吸综合征冠状病毒2感染的影响:一项全国性队列研究。
Front Med (Lausanne). 2024 Sep 4;11:1416197. doi: 10.3389/fmed.2024.1416197. eCollection 2024.
9
Unmasking the hidden impact of viruses on tuberculosis risk.揭示病毒对结核病风险的隐藏影响。
Trends Immunol. 2024 Sep;45(9):649-661. doi: 10.1016/j.it.2024.07.008. Epub 2024 Aug 23.
10
The TB burden in East Java, Indonesia, post-COVID-19.印度尼西亚东爪哇省新冠疫情后的结核病负担
IJTLD Open. 2024 Aug 1;1(8):372-373. doi: 10.5588/ijtldopen.24.0270. eCollection 2024 Aug.
活动性肺结核、后遗症与 COVID-19 合并感染:49 例首批队列。
Eur Respir J. 2020 Jul 9;56(1). doi: 10.1183/13993003.01398-2020. Print 2020 Jul.
4
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
5
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts.结核病、COVID-19 和移民:对两个队列中 69 例死亡患者的初步分析。
Pulmonology. 2020 Jul-Aug;26(4):233-240. doi: 10.1016/j.pulmoe.2020.05.002. Epub 2020 May 14.
6
Impact of the global COVID-19 outbreak on the management of other communicable diseases.全球新冠疫情对其他传染病管理的影响。
Int J Tuberc Lung Dis. 2020 May 1;24(5):547-548. doi: 10.5588/ijtld.20.0140.
7
New diseases and old threats: lessons from tuberculosis for the COVID-19 response.新疾病与旧威胁:结核病给COVID-19应对带来的教训
Int J Tuberc Lung Dis. 2020 May 1;24(5):544-545. doi: 10.5588/ijtld.20.0151.
8
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy.托珠单抗治疗伴有炎症过度反应和急性呼吸衰竭的重症 COVID-19 肺炎:意大利布雷西亚单中心 100 例患者研究。
Autoimmun Rev. 2020 Jul;19(7):102568. doi: 10.1016/j.autrev.2020.102568. Epub 2020 May 3.
9
Universal use of face masks for success against COVID-19: evidence and implications for prevention policies.普遍使用口罩以成功应对 COVID-19:预防政策的证据和影响。
Eur Respir J. 2020 Jun 18;55(6). doi: 10.1183/13993003.01260-2020. Print 2020 Jun.
10
Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers.SARS-CoV-2 的临床表型:对临床医生和研究人员的启示。
Eur Respir J. 2020 May 21;55(5). doi: 10.1183/13993003.01028-2020. Print 2020 May.